Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dominador Calamba

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Bioanalysis|June 26, 2015
Serum sample stability in ligand-binding assays: challenges in assessments of long-term, bench-top and multiple freeze-thawChris Macaraeg, Jessica Ortiz, Dominador Calamba, et al.
The AAPS Journal|August 13, 2015
Measurement of Free Versus Total Therapeutic Monoclonal Antibody in Pharmacokinetic Assessment is Modulated by Affinity, Incubation Time, and Bioanalytical PlatformJeffrey J Talbot, Dominador Calamba, Melody Pai, et al.
The AAPS Journal|April 5, 2011
Assessment of incurred sample reanalysis for macromolecules to evaluate bioanalytical method robustness: effects from imprecisionTheingi M Thway, Michael Eschenberg, Dominador Calamba, et al.
Pharmaceutical Research|December 23, 2011
Investigation of the mechanism of clearance of AMG 386, a selective angiopoietin-1/2 neutralizing peptibody, in splenectomized, nephrectomized, and FcRn knockout rodent modelsBenjamin Wu, Jessica Johnson, Marcus Soto, et al.
Journal of Pharmaceutical and Biomedical Analysis|October 24, 2009
Applications of a planar electrochemiluminescence platform to support regulated studies of macromolecules: benefits and limitations in assay rangeTheingi Thway, Chris Macaraeg, Dominador Calamba, et al.
Bioanalysis|November 19, 2010
Bioanalytical method requirements and statistical considerations in incurred sample reanalysis for macromoleculesTheingi M Thway, Chris R Macaraeg, Dominador Calamba, et al.
Pharmaceutical Research|March 23, 2024
A High Threshold of Biotherapeutic Aggregate Numbers is Needed to Induce an Immunogenic Response In Vitro, In Vivo, and in the ClinicJoseph R Cohen, Stephen R Brych, Siddharth Prabhu, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Bioanalysis|June 26, 2015
Serum sample stability in ligand-binding assays: challenges in assessments of long-term, bench-top and multiple freeze-thawChris Macaraeg, Jessica Ortiz, Dominador Calamba, et al.
The AAPS Journal|August 13, 2015
Measurement of Free Versus Total Therapeutic Monoclonal Antibody in Pharmacokinetic Assessment is Modulated by Affinity, Incubation Time, and Bioanalytical PlatformJeffrey J Talbot, Dominador Calamba, Melody Pai, et al.
The AAPS Journal|April 5, 2011
Assessment of incurred sample reanalysis for macromolecules to evaluate bioanalytical method robustness: effects from imprecisionTheingi M Thway, Michael Eschenberg, Dominador Calamba, et al.
Pharmaceutical Research|December 23, 2011
Investigation of the mechanism of clearance of AMG 386, a selective angiopoietin-1/2 neutralizing peptibody, in splenectomized, nephrectomized, and FcRn knockout rodent modelsBenjamin Wu, Jessica Johnson, Marcus Soto, et al.
Journal of Pharmaceutical and Biomedical Analysis|October 24, 2009
Applications of a planar electrochemiluminescence platform to support regulated studies of macromolecules: benefits and limitations in assay rangeTheingi Thway, Chris Macaraeg, Dominador Calamba, et al.
Bioanalysis|November 19, 2010
Bioanalytical method requirements and statistical considerations in incurred sample reanalysis for macromoleculesTheingi M Thway, Chris R Macaraeg, Dominador Calamba, et al.
Pharmaceutical Research|March 23, 2024
A High Threshold of Biotherapeutic Aggregate Numbers is Needed to Induce an Immunogenic Response In Vitro, In Vivo, and in the ClinicJoseph R Cohen, Stephen R Brych, Siddharth Prabhu, et al.
Pageof 1